SCHEMBL20755087

SCHEMBL20755087

c1ccc(N(c2ccc3oc4ccccc4c3c2)c2cccc3c4c(ccc23)C(c2ccccc2)(c2ccccc2)c2ccccc2-4)cc1

nearest known ligand 0.30

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20755328 0.95 AHR (0.31) KDM4EMEN1ALDH1A1MAPTHPGD
SCHEMBL20755822 0.91 KDM4E (0.32) KDM4EMEN1NPC1ALDH1A1MAPT
SCHEMBL26154318 0.90 — —
SCHEMBL17855080 0.90 KDM4E (0.34) KDM4EMEN1NPC1ALDH1A1MAPT
SCHEMBL21037263 0.89 AHR (0.31) KDM4EMEN1NPC1ALDH1A1MAPT
SCHEMBL17855402 0.89 AHR (0.32) KDM4EMEN1NPC1ALDH1A1MAPT
SCHEMBL17804915 0.89 KDM4E (0.33) KDM4EMEN1NPC1ALDH1A1MAPT
SCHEMBL17804783 0.88 KDM4E (0.32) KDM4EMEN1NPC1ALDH1A1MAPT
SCHEMBL17854456 0.87 KDM4E (0.33) KDM4EMEN1NPC1ALDH1A1MAPT
SCHEMBL25661701 0.87 AHR (0.31) KDM4EMEN1NPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10875825-B2 Amine-based compound and organic light-emitting device including the same Samsung Display Co., Lid. (KR) 2020-12-29 — — US disclosed
US-20190055187-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190055187-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME VDAC1, IARS2, TRMT1L KDM4E 899/4885MEN1 664/4885NPC1 2423/4885
US-10875825-B2 Amine-based compound and organic light-emitting device including the same VDAC1, IARS2, TRMT1L KDM4E 899/4885MEN1 664/4885NPC1 2423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback